Delivery Order SPE2DB24D2010-SPE2DB25FAAQV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,591.02 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Pediarix is a combined pediatric vaccine, indicating this delivery supports military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,555.93 to supply Pediarix 0.5 mL syringes on a firm fixed-price basis. This non-set-aside contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Pediarix is a combination pediatric vaccine used to provide immunization against multiple diseases including diphtheria, tetanus, pertussis,...
- The Defense Logistics Agency awarded a delivery order valued at $4,332.30 to AmerisourceBergen Drug Corp for Pediarix 0.5 ML syringes on February 24, 2025, with an ultimate completion date of February 25, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Pediarix is a combination pediatric vaccine used to provide immunization against multiple diseases, making...
- The Defense Logistics Agency awarded a delivery order valued at $2,920.27 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery of the pediatric vaccine product to support federal medical supply requirements. The contract is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,344.50 to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 ML syringes. This firm fixed price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a pediatric vaccine delivery under the agency's medical supply chain operations. The award utilizes no set-aside designation and was competitively awarded through open competition. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $1,299.69 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Pediarix 0.5 ML syringes. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vaccine product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $10,577.34 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Pediarix 0.5 mL syringes. This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. Performance will take place at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pediarix 0.5 mL syringes, valued at $2,797.02 under firm fixed pricing. This non-competitive delivery order, issued on July 31, 2025, with completion scheduled for August 1, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract utilizes AmerisourceBergen's existing indefinite delivery contract vehicle with the DLA, enabling rapid fulfillment...
- The Defense Logistics Agency awarded a $5,151.24 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Pediarix 0.5 ML syringes. This non-set-aside, firm fixed price contract is classified as a delivery order and has an ultimate completion date of July 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,253.00 to supply Pediarix 0.5 ML syringes. This contract, which is not set-aside, was competitively awarded with a firm fixed price structure and an ultimate completion date of July 21, 2025. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAQVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,719.50 to AmerisourceBergen Drug Corp for Pediarix 0.5 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Pediarix is a combination pediatric vaccine used to provide immunization against multiple diseases, reflecting the Defense Logistics Agency's ongoing need to supply critical medical commodities to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp serves as a prime vendor for military healthcare programs worldwide, supplying an extensive portfolio of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its comprehensive global pharmaceutical support contract vehicle, positions it as a key supplier supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 8/4/25 |